Literature DB >> 9660045

Amiodarone-induced severe hepatitis mediated by immunological mechanisms.

H W Breuer1, W Bossek, C Haferland, M Schmidt, H Neumann, J Gruszka.   

Abstract

A 64-year-old man developed a fulminant hepatitis 4 days after initiation of amiodarone treatment and a total dose of 7.1 g. The direct Coombs test was positive and became negative again soon after stopping treatment. Immediately after stopping treatment the extremely increased parameters of hepatic failure returned to normal again. A rechallenge with 200 mg of amiodarone was accompanied by a positive Coombs test which again became negative after several days. We conclude that the occurrence of an acute hepatitis soon after initiation of amiodarone treatment is mediated by immunological mechanisms. There should be high vigilance with respect to this rare life-threatening adverse drug reaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660045

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  4 in total

1.  Acute hepatitis after amiodarone infusion.

Authors:  Paulo Fonseca; Adelaide Dias; Helena Gonçalves; Aníbal Albuquerque; Vasco Gama
Journal:  World J Clin Cases       Date:  2015-10-16       Impact factor: 1.337

2.  Severe cholestatic jaundice in the elderly induced by low-dose amiodarone.

Authors:  Nimer Assy; G Khair; Sorina Schlesinger; Osamah Hussein
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.487

3.  Amiodarone-induced cirrhosis of liver: what predicts mortality?

Authors:  Nasir Hussain; Anirban Bhattacharyya; Suartcha Prueksaritanond
Journal:  ISRN Cardiol       Date:  2013-03-14

4.  Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature.

Authors:  Mohammad Nasser; Timothy R Larsen; Barryton Waanbah; Ibrahim Sidiqi; Peter A McCullough
Journal:  Drug Healthc Patient Saf       Date:  2013-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.